Williams Jones Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Williams Jones Wealth Management's PFE Position: Q1 2026 in Review
Williams Jones Wealth Management increased its Pfizer (PFE) stake by 1.9% in Q1 2026, buying an estimated $84.1K and bringing the position to 165,407 shares worth $4.64M. The position accounts for 0.06% of the portfolio, ranked #138.
Williams Jones Wealth Management first reported a position in PFE in Q3 2019 and has held it in 27 quarters since. The position peaked at $17.9M in Q2 2022. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Williams Jones Wealth Management held 165,407 shares of Pfizer worth $4.64M as of Q1 2026.
- Williams Jones Wealth Management bought 3,158 Pfizer shares in Q1 2026, an estimated $84.1K.
- Pfizer made up 0.06% of Williams Jones Wealth Management's portfolio in Q1 2026, its #138 holding.
- Williams Jones Wealth Management first reported a position in Pfizer in Q3 2019 and has held it in 27 quarters since.
- Williams Jones Wealth Management's Pfizer position peaked at $17.9M in Q2 2022.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Williams Jones Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.